腔内近距离放射治疗食管癌的特点和作用

张可领; 魏怡

腔内近距离放射治疗食管癌的特点和作用

张可领 , 魏怡

文章导航 > 国际放射医学核医学杂志 > 2003, 27 > 2: (62-65)

引用本文:

Citation:

腔内近距离放射治疗食管癌的特点和作用

张可领,
魏怡

200433 上海, 第二军医大学长海医院放疗科

作者简介: 张可领(1963-),男,主治医师,主要从事癌症放射治疗研究。;魏怡(1960-),女,主管技师,主要从事近距离放射治疗研究。;

中图分类号: R817.5

The characteristics and effects in the treatment of esophageal cancer with intraluminal brachytherapy

Department of Radiation Oncology, Changhai Hospital, the Second Military University, Shanghai 200433, China
CLC number: R817.5

摘要: 食管癌腔内近距离放疗是将放射源置于食管腔内进行放射治疗的一种方法,它可以作为表浅性食管癌或复发性食管癌的主要治疗手段,但更多的是将其作为局限性中晚期食管癌外照射后追加剂量照射的方法,这样可以提高肿瘤控制率和患者的生存率,对病变长度小于5cm或肿瘤局限于肌层的患者疗效更为明显。只要降低单次剂量、控制总剂量,腔内近距离放疗的早期反应可以耐受,后期并发症也可以得到控制。
- 食管癌 /
- 放射疗法 /
- 腔内近距离治疗
Abstract: Intraluminal Brachytherapy(ILBT) is one method of radiotherapy by delivering the radiation resource into the Intralumen of esophagus. ILBT has been proposed as the effective method in the treatment for superficial cancer of the esophagus. More frequently, it has been utilized as a boost after external beam radiotherapy (EBRT) in inoperable patients with localized esophageal carcinoma. ILBT with EBRT may improve local control and survival. The effect were found to be strongly correlated with tumor less than 5 cm in length or tumor confined to esophageal wall. The patients may tolerate in acute effects, and late complications may be controlled with lower single dose and reasonable total dose.
- esophageal cancer /
- radiation therapy /
- intraluminal brachytherapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Coia LR, Minsky BD, John MJ, et al. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus:results of the 1992-1994 patterns of care study[J]. Cancer, 1999, 85(12):2499-2505.
[2]	Tanisadak K, Teshima T, Inoue T, et al. National average for the process of radiation therapy in Japan by patterns of care study[J]. Jpn J Clin Oncol, 1999, 29(4):209-213.
[3]	Gaspar LE, Nag S, Herskovic A, et al. American Brachyther-apy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 1997, 38(1):127-132.
[4]	Taal BG, Aleman BM, Koning CC, et al. High dose rate brachytherapy before external beam irradiation in inoperaple esophageal cancer[J]. Br J Cancer, 1996, 74(9):1452-1457.
[5]	Akagi Y, Hirokawa Y, Kagemoto M, et al. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external beam irradiation of early stage esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 1999, 43(3):525-530.
[6]	Okawa T, Dokiya T, Nishio M, et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. JASTRO study group[J]. Int J Radiat Oncol Biol Phys, 1999, 45(3):623-628.
[7]	Yorozu A, Dokiya T, Oki Y, et al. Curative radiotherapy with high-dose-rate brachytherapy boost for localized esophageal cancer:dose-effect relationship of brachytherapy with the balloon type applicator system[J]. Radiother Oncol,1999,51(2):133-139.
[8]	Ogawa K, Toita T, Kakinohana Y, et al. Intraluminal brachytherapy using a balloon applicator for superficial esophageal carcinoma:importance of applicator confirmation by computed to-mography[J]. Radiat Med, 1999, 17(5):399-402.
[9]	Yorozu A, Dokiya T, Oki Y, et al. High-dose-rate brachythera-py boost following concurrent chemoradiotherapy for esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 1999, 45(2):271-275.
[10]	GasparLE, Winter K, Kocha WI, et al. A phase I/II study of external beam irradiation, brachytherapy, and concurrent chemotherapy for patients with localized esophageal cancer (Radiation Therapy Oncology Group Study 9702):final re-port[J]. Cancer, 2000, 88(5):988-995.
[11]	Sur RK, Donde B, Levin VC, et al. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 1998, 40(2):447-453.
[12]	Sharma V, Nahartshetty U, Dinshaw KA, et al. Palliation of advanced/recurrent esophageal carcinoma.with high dose rate brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2002, 52(2):310-315.
[13]	Vivekanandam S, Reddy KS, Velavan K, et al. External beam radiotherapy and intraluminal brachytherapy in ad-vanced inoperable esophageal cancer:JIPMER experience[J]. Am J Clin Oncol, 2001, 24(2):128-130.
[14]	Gaspar LE, Winter K, Kocha WI, et al. Swallowing function and weight change observed in a phase I/II study of external beam irradiation, brachytherapy, and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207)[J]. CancerJ, 2001, 7(5):388-394.
[15]	Someya M, Sakata K, Saito A, et al. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer[J]. Acta Oncol, 2002, 41(1):63-68.
[16]	Nishimura Y, Okuno Y, Ono K, et al. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma[J]. Cancer, 1999, 86(2):220-228.
[17]	Maingon P, d'Hombres A, Truc G, et al. High-dose-rate intraluminal brachytherapy for superficial cancer of the esophagus[J]. IntJ Radiat Oncol Biol Phys, 2000,46(1):71-76.
[18]	Nemoto K, Yamada S, Hareyama M, et al. Radiation therapy for superficial esophageal cancer:a comparison of radiotherapy methods[J]. Int J Radiat Oncol Biol Phys, 2001, 50(3):639-644.
[19]	Stuschke M, Stahl M, Wilke H,et al. Intraluminal brachytherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper thoracic and midthoracic esophagus[J]. Am J Clin Oncol, 2000, 20(3):233-238.
[20]	Ilson DH. New developments in the treatment of esophageal cancer[J]. Curr Oncol Rep, 2002, 4(3):213-221.

[1]	王利利 . 食管癌放射治疗中对正常组织的防护. 国际放射医学核医学杂志, 2003, 27(3): 138-140.
[2]	陈建伟 . 放射性核素近距离治疗血管再狭窄的现状和进展. 国际放射医学核医学杂志, 2002, 26(3): 97-100.
[3]	王峰 . ¹⁸F-FDG PET对原发性食管癌和复发性食管癌的诊断价值. 国际放射医学核医学杂志, 2004, 28(1): 15-17.
[4]	蔡晓君 , 秦颂兵 , 徐晓婷 , 周菊英 . PET-CT图像融合技术在非小细胞肺癌适形放射治疗中的应用价值. 国际放射医学核医学杂志, 2008, 32(3): 143-146.
[5]	阎军艳 , 李险峰 . 放射治疗在晚期甲状腺乳头状癌中的研究进展. 国际放射医学核医学杂志, 2017, 41(1): 59-62,73. doi: 10.3760/cma.j.issn.1673-4114.2017.01.011
[6]	谢彦婷 , 郑容 . ¹⁸F-FDG PET/CT在食管癌放疗中的应用. 国际放射医学核医学杂志, 2013, 37(1): 42-46. doi: 10.3760/cma.j.issn.1673-4114.2013.01.012
[7]	何蕊 , 朱高红 . 甲状腺髓样癌靶向治疗的研究进展. 国际放射医学核医学杂志, 2018, 42(2): 154-160. doi: 10.3760/cma.j.issn.1673-4114.2018.02.010
[8]	邱新峰 , 刘强 . 鼻咽癌放疗致放射性脑损伤的临床分析. 国际放射医学核医学杂志, 2008, 32(3): 191-191.
[9]	陈跃 . 颅内肿瘤放射治疗后¹⁸F-氟代脱氧葡萄糖PET的临床意义. 国际放射医学核医学杂志, 2006, 30(2): 97-99.
[10]	杜芳芳 , 郭阳 , 姜炜 . 脑转移瘤的放射治疗进展. 国际放射医学核医学杂志, 2015, 39(4): 328-331. doi: 10.3760/cma.j.issn.1673-4114.2015.04.012

点击查看大图

计量

文章访问数: 1069
HTML全文浏览量: 110
PDF下载量: 4

腔内近距离放射治疗食管癌的特点和作用

张可领
魏怡

作者简介:张可领(1963-),男,主治医师,主要从事癌症放射治疗研究。;魏怡(1960-),女,主管技师,主要从事近距离放射治疗研究。

200433 上海, 第二军医大学长海医院放疗科

收稿日期: 2002-06-24

关键词:

摘要: 食管癌腔内近距离放疗是将放射源置于食管腔内进行放射治疗的一种方法,它可以作为表浅性食管癌或复发性食管癌的主要治疗手段,但更多的是将其作为局限性中晚期食管癌外照射后追加剂量照射的方法,这样可以提高肿瘤控制率和患者的生存率,对病变长度小于5cm或肿瘤局限于肌层的患者疗效更为明显。只要降低单次剂量、控制总剂量,腔内近距离放疗的早期反应可以耐受,后期并发症也可以得到控制。